Walleye Capital’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Other funds holding HRMY
Walleye Capital's HRMY Position: Q3 2026 in Review
Walleye Capital sold out of Harmony Biosciences (HRMY) in Q3 2026, closing a stake of 44,372 shares — an estimated $1.62M sold.
Walleye Capital first reported a position in HRMY in Q1 2023 and held it in 4 quarters. The position peaked at $6.9M in Q2 2023. 353 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.
- Walleye Capital reported no remaining Harmony Biosciences position as of Q3 2026 after selling out during the quarter.
- Walleye Capital sold 44,372 Harmony Biosciences shares in Q3 2026, an estimated $1.62M.
- Walleye Capital first reported a position in Harmony Biosciences in Q1 2023 and held it in 4 quarters.
- Walleye Capital's Harmony Biosciences position peaked at $6.9M in Q2 2023.
- 353 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.